GlassScriptPhysician profile
Laurel Ainsley Barnes
NPI 1083092142
$2,336.04
in general payments reported to CMS, 2019-2025
15 companies · $83.19 in 2025
The $83.19 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $188 · 2023: $1,853 · 2024: $211 · 2025: $83.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,149 · Food and Beverage: $789 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,148.78 |
| Food and Beverage | $788.95 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,417.08 | 2023-2024 | Plasmablade(Tm) |
| Leica Microsystems INC. | $210.00 | 2023 | |
| Lilly USA, LLC | $168.44 | 2023 | Verzenio |
| Astrazeneca Pharmaceuticals LP | $160.06 | 2022-2023 | Enhertu |
| Bioventus LLC | $109.03 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $51.81 | 2025 | |
| Ethicon US, LLC | $42.77 | 2023 | Megadyne |
| Merck Sharp & Dohme LLC | $37.24 | 2022-2023 | Lynparza, Keytruda |
| Boston Scientific Corporation | $33.12 | 2024 | Watchman Flx |
| Smith+Nephew, INC. | $23.76 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.66 | 2023 | Alunbrig |
| Integra Lifesciences Corporation | $18.91 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Coopersurgical, INC. | $16.29 | 2025 | Onetrac Lx |
| Cardinal Health 414 LLC | $15.09 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Seagen INC. | $12.78 | 2023 | Padcev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.